首页> 外文期刊>Cancer: A Journal of the American Cancer Society >The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy.
【24h】

The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy.

机译:驱动蛋白家族蛋白在肿瘤发生和发展中的作用:潜在的生物标志物和癌症治疗的分子靶标。

获取原文
获取原文并翻译 | 示例
           

摘要

The kinesin superfamily contains a conserved class of microtubule-dependent molecular motor proteins that possess an adenosine triphosphatase activity and motion characteristics. The active movement of kinesins supports several cellular functions, including mitosis, meiosis, and the transport of macromolecules. Mitosis is a process of eukaryotic cell division that involves the division of nuclei, cytoplasm, organelles, and the cell membrane into 2 daughter cells with roughly equivalent portions of these cellular components. Any errors in this process could result in cell death, abnormality (such as gene deletion, chromosome translocation, or duplication), and cancer. Because mitosis is complex and highly regulated, alteration of kinesin expression or function could lead to carcinogenesis. Moreover, because human cancer is a gene-related disease involving abnormal cell growth, targeting kinesins may create a novel strategy for the control of human cancer. Indeed, several such drugs are being tested successfully in the clinic. In this review, the authors discuss in detail the structure and function of kinesins, the correlation of kinesin expression with tumorigenesis and progression, and the development of biomarkers and cancer-targeted therapy involving the kinesin family proteins.
机译:驱动蛋白超家族包含一类保守的微管依赖性分子运动蛋白,其具有腺苷三磷酸酶活性和运动特性。驱动蛋白的主动运动支持多种细胞功能,包括有丝分裂,减数分裂和大分子的运输。有丝分裂是真核细胞分裂的过程,涉及将核,细胞质,细胞器和细胞膜分裂成两个子细胞,这些子细胞具有大致相等的部分。此过程中的任何错误都可能导致细胞死亡,异常(例如基因缺失,染色体易位或重复)和癌症。由于有丝分裂是复杂的且受高度调节的,因此驱动蛋白表达或功能的改变可能导致癌变。此外,由于人类癌症是一种涉及异常细胞生长的基因相关疾病,因此靶向驱动蛋白可以为控制人类癌症创造新的策略。实际上,几种此类药物正在临床中成功测试。在这篇综述中,作者详细讨论了驱动蛋白的结构和功能,驱动蛋白表达与肿瘤发生和发展的相关性,以及涉及驱动蛋白家族蛋白的生物标志物和癌症靶向疗法的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号